These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Inhibition of dihydropyrimidine dehydrogenase by 5-propynyluracil, a metabolite of the anti-varicella zoster virus agent netivudine. Peck R; Wiggs R; Callaghan J; Wootton R; Crome P; Fraser I; Frick L; Posner J Clin Pharmacol Ther; 1996 Jan; 59(1):22-31. PubMed ID: 8549030 [TBL] [Abstract][Full Text] [Related]
7. Oral bioavailability and anti-simian varicella virus efficacy of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) in monkeys. Soike K; Huang JL; Tu JI; Stouffer B; Mitroka JG; Swerdel M; Olsen S; Bonner DP; Tuomari AV; Field AK J Infect Dis; 1992 Apr; 165(4):732-6. PubMed ID: 1313071 [TBL] [Abstract][Full Text] [Related]
8. Preclinical pharmacology and pharmacokinetics of the anti-hepatitis virus agent 2'-fluoro-5-ethyl-1-beta-D-arabinofuranosyluracil in mice and rats. Kong XB; Vidal P; Tong WP; Chiang J; Gloff CA; Chou TC Antimicrob Agents Chemother; 1992 Jul; 36(7):1472-7. PubMed ID: 1510443 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics of 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)uracil in woodchucks. Witcher JW; Boudinot FD; Baldwin BH; Ascenzi MA; Tennant BC; Du JF; Chu CK Antimicrob Agents Chemother; 1997 Oct; 41(10):2184-7. PubMed ID: 9333045 [TBL] [Abstract][Full Text] [Related]
10. Sorivudine: a potent inhibitor of varicella zoster virus replication. Whitley RJ Adv Exp Med Biol; 1996; 394():41-4. PubMed ID: 8815706 [TBL] [Abstract][Full Text] [Related]
11. Mechanism of selective inhibition of varicella zoster virus replication by 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil. Yokota T; Konno K; Mori S; Shigeta S; Kumagai M; Watanabe Y; Machida H Mol Pharmacol; 1989 Aug; 36(2):312-6. PubMed ID: 2549386 [TBL] [Abstract][Full Text] [Related]
12. Acyclovir--and beyond. Darby G J Int Med Res; 1994; 22 Suppl 1():33A-42A. PubMed ID: 8063023 [TBL] [Abstract][Full Text] [Related]
13. Automated sequential trace enrichment of dialysates combined with high-performance liquid chromatography and automated heart-cutting for the determination of the nucleoside 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)uracil and its metabolite 5-propynyluracil in urine. Cooper JD; Sheung CT; Buick AR J Chromatogr; 1994 Jan; 652(1):15-21. PubMed ID: 8014223 [TBL] [Abstract][Full Text] [Related]
14. Discontinuous oral absorption pharmacokinetic model and bioavailability of 1-(2-fluoro-5-methyl-beta-L-arabinofuranosyl)uracil (L-FMAU) in rats. Wright JD; Ma T; Chu CK; Boudinot FD Biopharm Drug Dispos; 1996 Apr; 17(3):197-207. PubMed ID: 8983395 [TBL] [Abstract][Full Text] [Related]
15. The absolute bioavailability and metabolic disposition of the novel antimigraine compound zolmitriptan (311C90). Seaber E; On N; Dixon RM; Gibbens M; Leavens WJ; Liptrot J; Chittick G; Posner J; Rolan PE; Pack RW Br J Clin Pharmacol; 1997 Jun; 43(6):579-87. PubMed ID: 9205817 [TBL] [Abstract][Full Text] [Related]
16. The effect of sorivudine on dihydropyrimidine dehydrogenase activity in patients with acute herpes zoster. Yan J; Tyring SK; McCrary MM; Lee PC; Haworth S; Raymond R; Olsen SJ; Diasio RB Clin Pharmacol Ther; 1997 May; 61(5):563-73. PubMed ID: 9164418 [TBL] [Abstract][Full Text] [Related]
17. Pharmacokinetics of 1-(2-deoxy-2-fluoro-beta-L-arabinofuranosyl)-5-methyluracil (L-FMAU) in rats. Wright JD; Ma T; Chu CK; Boudinot FD Pharm Res; 1995 Sep; 12(9):1350-3. PubMed ID: 8570534 [TBL] [Abstract][Full Text] [Related]
18. Determination of 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)-uracil and a metabolite, 5-propynyluracil, in plasma using ASTED (automated sequential trace enrichment of dialysates) combined, on-line, with high-performance liquid chromatography. Buick AR; Sheung CT J Chromatogr; 1993 Jul; 617(1):65-70. PubMed ID: 8376539 [TBL] [Abstract][Full Text] [Related]
19. Biotransformation and elimination of [2-14C]-1-(2-deoxy-2'-fluoro-beta-D -arabinofuranosyl)-5-iodocytosine in immunosuppressed patients with herpesvirus infections. Feinberg A; Leyland-Jones B; Fanucchi MP; Hancock C; Fox JJ; Watanabe KA; Vidal PM; Williams L; Young CW; Philips FS Antimicrob Agents Chemother; 1985 May; 27(5):733-8. PubMed ID: 2990323 [TBL] [Abstract][Full Text] [Related]
20. Absorption, disposition, and metabolism of [14C]didanosine in the beagle dog. Kaul S; Shyu WC; Shukla UA; Dandekar KA; Barbhaiya RH Drug Metab Dispos; 1993; 21(3):447-53. PubMed ID: 8100500 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]